Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid... see more

TSXV:MIR - Post Discussion

MedMira Inc > Has the outlook changed? No
View:
Post by MrHODL on Apr 30, 2021 11:01am

Has the outlook changed? No

Hello fellow investors, although stock price is taking a dip to 52 week low, ask yourself if a correction is really justified or people just getting impatient because they don't know whats going on at MedMira.

A quick overview of some promising facts:
  • MedMira developed an improved antibody test (Revealcovid-10 PLUS) and submitted to FDA in January. Awaiting FDA EUA or full approval.
  • Mentioned they were in "final discussions" with FDA
  • MedMira introduced a newly developed antigen test (saliva based) and we are waiting to get news about validation data regarding its accuracy and sensitivity as well as FDA submission
  • New trademarks have been registered for products we yet don't know about
  • Hermes Chan (CEO) executed his options to buy more MedMira shares
  • RedAlpine (major investor in Medmira AG) sold its position due to fund termination. There are rumours mentioning that MedMira's owner family bought the entire position.
  • Production capacity should be ready and can be extended to 50.000 units per day
  • MedMira demonstrated the strenth of its patented technology to be adaptable for new virus variants and how quick new products can be build on top of it
  • MedMira is still hiring new staff
  • Covid is here to stay (unfortunately)

Wish you all the best
Comment by Skowhegan on Apr 30, 2021 11:08am
Seems like Meile was in top shape with his tongue... swirling like a snake into your synapsis... Kratz was right and I apologise to everyone on ICO - Many sorry. Worst investment
Comment by EtheGreat on May 02, 2021 9:49am
'MrHODL' U are correct they are still Hiring ! I admire Ur Enthusiasm and No Flinching or Blinking (LoL)... I hope they get a Stategic Partner like a big Pharma but FDA Approval Process is Bananas Awful. -- EtheGreat or Not ?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse